<p>Cresco Labs Inc. reported a net loss attributable to the company of $17.1 million for the three months ended September 30, 2025, compared to a net loss of $10.5 million for the same period in 2024. The net loss per share was $0.05, up from $0.03 in the prior year. Total comprehensive loss attributable to Cresco Labs Inc. for the quarter was $17.3 million, compared to $10.4 million in the previous year. As of September 30, 2025, the company had working capital of $145.3 million. Cresco Labs Inc. operates in one segment, focusing on the cultivation, manufacturing, distribution, and sale of cannabis, and generated 100% of its revenue in the U.S. during the reported periods. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cresco Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001832928-25-000038), on November 07, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

CRLBF

<p>Cresco Labs Inc. reported a net loss of $17.1 million for Q3 2025, compared to a loss of $10.5 million in Q3 2024. The net loss per share increased to $0.05 from $0.03. Total comprehensive loss for the quarter was $17.3 million, up from $10.4 million the previous year. As of September 30, 2025, the company had working capital of $145.3 million and operates solely in the U.S. cannabis market.</p>

Cresco Labs posts quarterly net loss of $17.1 million